Watchlist Price Alert

Galectin Therapeutics Inc... (GALT)

NASDAQ: GALT · Real-Time Price · USD

3.29

0.90 (37.66%)

At close: Jun 18, 2025, 3:59 PM

Galectin Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	80K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	10K	n/a	9K	9K	9K	8K	n/a	n/a	8K	n/a	7K	10K	11K	10K	10K	10K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	-9K	-9K	71K	-8K	n/a	n/a	-8K	n/a	-7K	-10K	-11K	-10K	-10K	-10K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	n/a	-12.43M	-9.07M	-11.29M	-9.65M	-9.56M	-9.17M	-9M	-10.34M	-10.63M	-8.12M	-9.66M	-9.94M	-7.42M	-8.24M	-8.19M	-6.32M	-7.83M	-5.93M	-6.1M	-3.58M	-5.19M	-2.86M	-3.02M	-2.37M	-2.98M	-2.68M	-3.76M	-4.18M	-2.37M	-4.41M	-4.51M	-4.95M	-4.6M	-4.54M	-5.53M	-6.81M
Interest Income	35K	84K	93K	80K	80K	74K	62K	50K	44K	30K	18K	3K	1K	n/a	1K	1K	1K	2K	5K	9K	50K	73K	101K	43K	14K	15K	15K	4K	4K	3K	6K	6K	9K	8K	11K	12K	14K
Pretax Income	-9.63M	-11.97M	-11.22M	-12.37M	-11.49M	-10M	-10.43M	-9.11M	-11.53M	-10.63M	-8.6M	-9.61M	-9.93M	-7.22M	-8.52M	-8.45M	-6.34M	-7.85M	-5.94M	-6.11M	-3.56M	-5.14M	-2.78M	-3M	-2.38M	-3.05M	-2.75M	-3.84M	-4.26M	-2.38M	-4.41M	-4.51M	-4.94M	-4.59M	-4.53M	-5.52M	-6.8M
Net Income	-9.63M	-11.97M	-11.22M	-12.37M	-11.49M	-10M	-10.43M	-9.11M	-11.53M	-10.63M	-8.6M	-9.61M	-9.93M	-7.22M	-8.52M	-8.45M	-6.34M	-7.85M	-5.94M	-6.11M	-3.56M	-5.14M	-2.78M	-3M	-2.38M	-3.05M	-2.75M	-3.84M	-4.26M	-2.38M	-4.41M	-4.51M	-4.94M	-4.59M	-4.53M	-5.52M	-6.8M
Selling & General & Admin	1.41M	1.32M	1.47M	1.48M	1.59M	1.33M	1.43M	1.63M	1.54M	1.63M	1.52M	1.59M	1.88M	1.57M	1.63M	1.74M	1.42M	1.46M	1.15M	1.42M	1.44M	1.39M	1.36M	1.5M	1.72M	1.79M	1.18M	2.28M	1.88M	1.37M	911K	1.07M	1.17M	1.17M	1.25M	1.3M	2.44M
Research & Development	6.49M	11.11M	7.59M	9.81M	8.05M	8.23M	7.73M	7.37M	8.8M	9.01M	6.6M	8.07M	8.06M	5.86M	6.61M	6.45M	4.9M	6.37M	4.78M	4.68M	2.14M	3.8M	1.5M	1.52M	646K	1.19M	1.5M	1.48M	2.3M	1M	3.5M	3.44M	3.77M	3.43M	3.29M	4.23M	4.38M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	7.9M	12.43M	9.07M	11.29M	9.65M	9.56M	9.17M	9M	10.34M	10.63M	8.12M	9.66M	9.94M	7.42M	8.24M	8.19M	6.32M	7.83M	5.93M	6.1M	3.58M	5.19M	2.86M	3.02M	2.37M	2.98M	2.68M	3.76M	4.18M	2.37M	4.41M	4.51M	4.95M	4.6M	4.54M	5.53M	6.81M
Interest Expense	-1.74M	1.73M	1.49M	1.27M	1.05M	847K	835K	650K	460K	308K	269K	229K	227K	272K	111K	85K	22K	22K	22K	21K	22K	22K	22K	21K	22K	80K	87K	85K	84K	12K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	12.43M	9.07M	11.29M	9.65M	9.56M	9.17M	9M	10.34M	10.63M	8.12M	9.66M	9.94M	7.42M	8.24M	8.19M	6.32M	7.83M	5.93M	6.1M	3.58M	5.19M	2.86M	3.02M	2.37M	2.98M	2.68M	3.76M	4.18M	2.37M	4.41M	4.51M	4.95M	4.6M	4.54M	5.53M	6.81M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	63.2M	62.74M	62.28M	62.23M	61.98M	60.16M	59.7M	59.58M	59.48M	59.43M	59.4M	59.39M	59.35M	58.53M	59.29M	58.31M	57.13M	57.08M	57.05M	57.03M	56.96M	41.94M	56.63M	50.3M	44.98M	37.51M	40.92M	38.23M	37.28M	32.72M	35.16M	34.69M	33.93M	32.31M	29.28M	29.02M	28.83M
Shares Outstanding (Diluted)	63.2M	62.74M	62.28M	62.23M	61.98M	60.16M	59.7M	59.58M	59.48M	59.43M	59.4M	59.39M	59.35M	58.53M	59.29M	58.31M	57.13M	57.08M	57.05M	57.03M	56.96M	42.47M	56.63M	50.3M	44.98M	40.92M	40.92M	38.23M	37.28M	35.16M	35.16M	34.69M	33.93M	32.31M	29.28M	29.02M	28.83M
EPS (Basic)	-0.15	-0.19	-0.18	-0.2	-0.19	-0.16	-0.24	-0.15	-0.19	-0.51	-0.14	-0.16	-0.17	-0.12	-0.14	-0.15	-0.11	-0.14	-0.1	-0.11	-0.06	-0.09	-0.05	-0.06	-0.2	-0.07	-0.07	-0.11	-0.12	-0.07	-0.13	-0.14	-0.15	-0.16	-0.16	-0.2	-0.24
EPS (Diluted)	-0.15	-0.19	-0.18	-0.2	-0.19	-0.16	-0.24	-0.15	-0.19	-0.51	-0.14	-0.16	-0.17	-0.12	-0.14	-0.15	-0.11	-0.14	-0.1	-0.11	-0.06	-0.09	-0.05	-0.06	-0.2	-0.07	-0.07	-0.11	-0.12	-0.07	-0.13	-0.14	-0.15	-0.16	-0.16	-0.2	-0.24
EBITDA	n/a	-10.23M	-9.72M	-11.09M	-10.43M	-9.14M	-9.59M	-8.46M	-11.04M	-10.32M	-8.32M	-9.38M	-9.7M	-6.94M	-8.4M	-8.35M	-6.31M	-7.82M	-5.91M	-6.08M	-3.52M	-5.11M	-2.75M	-2.97M	-2.34M	-2.97M	-2.67M	-3.75M	-4.17M	-2.37M	-4.41M	-4.51M	-4.94M	-4.59M	-4.54M	-5.53M	-6.81M
EBIT	n/a	-10.24M	-9.73M	-11.1M	-10.44M	-9.15M	-9.59M	-8.46M	-11.07M	-10.33M	-8.33M	-9.38M	-9.71M	-6.95M	-8.41M	-8.36M	-6.32M	-7.83M	-5.92M	-6.09M	-3.53M	-5.12M	-2.76M	-2.98M	-2.35M	-2.97M	-2.67M	-3.75M	-4.17M	-2.35M	-4.41M	-4.51M	-4.94M	-4.59M	-4.54M	-5.53M	-6.81M
Depreciation & Amortization	n/a	10K	9K	9K	9K	9K	8K	n/a	32K	8K	7K	7K	10K	11K	10K	10K	10K	9K	10K	8K	9K	9K	8K	8K	10K	n/a	n/a	n/a	n/a	-24K	n/a	n/a	1K	2K	2K	2K	1K